EP3377176
Aðferð til að meðhöndla sjúklinga sem rívaroxaban og verapamíl eru gefin samhliða
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
21.2.2017EP published:
20.10.2021EP application number:
17757069.4
EP translation filed:
14.12.2021Grant published:
15.1.2022EPO information:
European Patent Register
Max expiry date:
20.2.2037Expiry date:
20.2.2025
Title:
METHOD OF TREATING PATIENTS COADMINISTERED RIVAROXABAN AND VERAPAMIL
Timeline
Today
21.2.2017EP application
20.10.2021EP Publication
14.12.2021Translation submitted
15.1.2022Registration published
20.2.2025Expires
Owner
Name:
Morgandane Scientific, LLCAddress:
2012 Seadrift Drive, Corona Del Mar, CA 92625, US
Inventor
Name:
PATEL, MaulikAddress:
Burlingame, CA 94010, US
Name:
SRINIVASAN, SundarAddress:
Corona Del Mar, CA 92625, US
Name:
CHOW, ChristinaAddress:
Seattle Washington 98112, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201662298555 PDate:
23.2.2016Country:
US
Classification
Categories:
A61K 31/277, A61K 31/5377, A61P 7/02, A61P 9/12
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 5.1.2022
Expires: 20.2.2023
Payer: Árnason Faktor ehf.
Number: 7
Paid: 5.1.2023
Expires: 20.2.2024
Payer: Árnason Faktor ehf.
Number: 7
Paid: 5.1.2023
Expires: 20.2.2024
Payer: Árnason Faktor ehf.
Number: 8
Paid: 9.1.2024
Expires: 20.2.2025
Payer: Árnason Faktor ehf.